PHIO PHARMACEUTICALS CORP. Operating Loss Carryforwards
PHIO PHARMACEUTICALS CORP. (PHIO) had Operating Loss Carryforwards of $46.80 million as of 2014-12-31, per its 10-K filed 2015-03-30.
Discontinued › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2015-03-30
- 2014-12-31: Operating Loss Carryforwards $46.80M.
- 2013-12-31: Operating Loss Carryforwards $30.30M.
- 2012-12-31: Operating Loss Carryforwards $7.80M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2014-12-31 | $46.80M 10-K · filed 2015-03-30 |
| 2013-12-31 | $30.30M 10-K · filed 2014-03-28 |
| 2012-12-31 | $7.80M 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |